Stocksigma LogoStocksigma Logo

Aurobindo Pharma Dilutes Stake in Step-Down Subsidiary A1 Biochem Labs

Aurobindo Pharma鈥檚 wholly owned subsidiary, Apitoria Pharma, diluted its holding in step-down subsidiary A1 Biochem Labs from 100% to 80% on a fully

Aurobindo Pharma Dilutes Stake in Step-Down Subsidiary A1 Biochem Labs

Aurobindo Pharma Ltd 路 Others (Uncategorized) 路 01 Oct 2026, 6:24 pm

Aurobindo Pharma Dilutes Stake in Step-Down Subsidiary A1 Biochem Labs Aurobindo Pharma鈥檚 wholly owned subsidiary, Apitoria Pharma, diluted its holding in step-down subsidiary A1 Biochem Labs from 100% to 80% on a fully diluted basis. Former promoter Dr. Rajendra Gadikota subscribed to 89,94,500 equity shares (INR 9.18 Cr) and 2,41,05,500 Compulsory Convertible Debentures (INR 24.62 Cr), securing a 20% stake for INR 33.80 Cr on 30th Sep'26. A1 Labs remains a subsidiary, with Apitoria retaining an option to reacquire the 20% stake in the future under agreed definitive terms.

Original exchange filing (PDF)

More announcements from Aurobindo Pharma Ltd

All Aurobindo Pharma Ltd announcements